Kairos Pharma, Ltd. (KAPA) AMEX
0.46
-0.0056(-1.20%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Kairos Pharma, Ltd.
Address
2355 Westwood Blvd.
Los Angeles, CA 90064
United States of America (the)
Phone
310-948-2356
Website
Sector
Healthcare
Industry
Biotechnology
Employees
1
First IPO Date
September 16, 2024
Key Executives
| Name | Title | Pay | Year Born |
| John S. Yu | Chief Executive Officer, Chairman & Secretary | 287,500 | 1964 |
| Douglas W. Samuelson | Chief Financial Officer | 112,500 | 1960 |
| Ramachandran Murali | Vice President of Research & Development | 127,500 | 1960 |
| Neil A. Bhowmick | Chief Scientific Officer | 156,250 | 1971 |
Description
Kairos Pharma, Ltd. operates as a clinical-stage biopharmaceutical company that develops therapeutics for cancer patients. Its therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. Kairos Pharma, Ltd. was formerly known as NanoGB13, Inc. and changed its name to Kairos Pharma, Ltd. in July 2016. The company was incorporated in 2013 and is based in Los Angeles, California.
